| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| 21st Century Oncology Holdings (TBA) | Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities | $300.00 | n.a. | |||
| Aerohive Networks (HIVE) | Goldman Sachs/ BofA Merrill Lynch | $75.00 | n.a. | |||
| Akebia Therapeutics (AKBA) | Morgan Stanley/ Credit Suisse | $75.00 | n.a. | |||
| Amber Road (AMBR) | Stifel | $75.00 | n.a. | |||
| Castlight Health (CSLT) | Goldman Sachs/ Morgan Stanley | $100.00 | n.a. | |||
| La Quinta Holdings (TBA) | J.P. Morgan/ Morgan Stanley | $100.00 | n.a. | |||
| MediWound Ltd. (MDWD) | Credit Suisse/ Jefferies/ BMO Capital Markets | $86.25 | n.a. | |||
| PQ Holdings (PQH) | BofA Merrill Lynch/ Credit Suisse/ J.P. Morgan | $450.00 | n.a. | |||
| Q2 Holdings (QTWO) | J.P. Morgan/ Stifel | $138.00 | n.a. | |||
| Rimini Street (RMNI) | UBS Investment Bank/ Piper Jaffray/ JMP Securities | $60.00 | n.a. | |||
| Stalwart Tankers (STST) | Jefferies/ Wells Fargo Securities/ Global Hunter Securities | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Audeo Oncology (AURX) | Leerink Swann/ Oppenheimer | 3.25 | $14.00 | $16.00 | $48.75 | 1-Star |
| New Terms | ||||||
| Boulevard Acquisition (BLVDU) (u) | Citigroup | 17.50 | $10.00 | $10.00 | $175.00 | 1-Star |
| Installed Building Products (IBP) | Deutsche Bank Securities/ UBS Investment Bank | 7.45 | $14.00 | $16.00 | $111.75 | 1-Star |
| Lumenis Ltd (LMNS) | Goldman Sachs/ Credit Suisse/ Jefferies | 6.25 | $15.00 | $17.00 | $100.00 | n.a. |
| Recro Pharma (REPH) | Aegis Capital Corp | 2.55 | $10.00 | $12.00 | $28.00 | n.a. |
| TriNet Group (TNET) | J.P. Morgan/ Morgan Stanley/ Deutsche Bank Securities | $250.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 10, 2014 | Manager(s) | Offered | Raised | Price | 2/14/14 | Change |
| Installed Building Products (IBP) | Deutsche Bank Securities/ UBS Investment Bank | 7.45 | $81.95 | $11.00 | $13.00 | 18.18% |
| Flexion Therapeutics (FLXN) | BMO Capital Markets/ Wells Fargo Securities | 5.00 | $65.00 | $13.00 | $15.06 | 15.85% |
| Talmer Bancorp (TLMR) | Keefe, Bruyette & Woods (A Stifel Company )/ J.P.Morgan | 15.56 | $202.22 | $13.00 | $13.95 | 7.31% |
| Concert Pharmaceuticals (CNCE) | UBS Investment Bank/ Wells Fargo Securities | 6.00 | $84.00 | $14.00 | $14.07 | 0.50% |
| Boulevard Acquisition (BLVDU) | Citigroup | 17.50 | $175.00 | $10.00 | $10.01 | 0.10% |
| NephroGenex (NRX) | Aegis Capital Corp | 3.10 | $37.20 | $12.00 | $11.90 | -0.83% |
| Amedica (AMDA) | JMP Securities | 3.50 | $20.13 | $5.75 | $5.68 | -1.22% |
| Inogen (INGN) | J.P. Morgan/ Leerink Swann | 4.41 | $70.59 | $16.00 | $15.15 | -5.31% |
| Eagle Pharmaceuticals (EGRX) | Piper Jaffray/ William Blair | 3.33 | $50.00 | $15.00 | $12.80 | -14.67% |
